[Modified insulin treatment of therapy refractory schizophrenic disorders].
Subliminal hypoglycemia therapy (subcoma therapy, modified insulin therapy) is rarely practised in modern psychiatry. This study reports on the therapy of 105 patients (2619 single treatments) suffering from therapy-resistant schizophrenia. Evaluation was retrospective. Remarkably, 46.7% of the patients responded positively to a 4-6 week course of insulin therapy. In 26.6%, the effect was moderate. Tolerance ist good.